The new drug development -- collaborative and people-powered

Guest Commentary: EMD Serono and iConquerMS discuss their approach to patient-centricity

In recent years, the healthcare ecosystem has been experiencing a paradigm shift in how it engages with the people at its center: patients.

Patients are demanding to be viewed first as people, with lives and priorities that exist outside the door of the clinical examination room. They insist on having a voice in how the conditions that impact them are studied and treated.

This shift in engagement requires a corresponding shift in our clinical research infrastructure -- one that keeps patients’ needs and priorities at its core.

A new model must be created to meaningfully incorporate patient participation, and patient-contributed health information, through all aspects of clinical trials, with patients

Read the full 1097 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers